Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
2.8%
1w
1.9%
1m
2.8%
3m
13.6%
6m
33.7%
1y
12.3%
all
16.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 875 2.8%
735
977
Company Overview

Sales
2,002 Cr
Growth: 15.7%
Profit after Tax
575 Cr
Growth: -2.7%
Large Cap
49,309 Cr
P/E: 83.9x
Industry P/E: 35.1x
Fundamentals

Sales (Cr) ₹ 2,002
Growth 15.7%
EBITDA 39.6%
P/S 24.0x
Dividend 0.0%
P/E 83.9x
Book Value ₹ 56.1
PEG Ratio 5.3x
ROE 19.6%
P/B 15.2x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Investors (1)
Followers (1)